- Dr. Joseph Rosado has been named Chief Medical Officer at VitalPoint Technologies Inc., where he will oversee increasing access to new ketamine therapies.
- Dr. Rosado brings a wealth of experience from his extensive career in healthcare, including expertise in clinical nutrition and healthcare management.
- He has held significant leadership roles and is currently the medical director of a mental/behavioral health clinic in St. Augustine, FL and an adjunct professor at Lake Erie College of Osteopathic Medicine.
- Robert Yrshus, VitalPoint’s Executive Chairman, commends Dr. Rosado for his commitment to medical advancements and enhancing patient care.
- Dr. Rosado looks forward to advancing the field of ketamine therapy and making a positive impact on healthcare through his role at VitalPoint.
Houston, Texas – September 26th, 2024 – VitalPoint Technologies Inc., a leader in innovative healthcare solutions, is thrilled to announce the appointment of Dr. Joseph Rosado as the Chief Medical Officer. In this role, Dr. Rosado will play a pivotal role in the development of AppCo which is aimed at providing access to cutting-edge ketamine treatments for chronic mental/behavioral health conditions.
Dr. Rosado is a seasoned healthcare professional with over 40 years of experience across a diverse range of roles, including nurse’s aide, emergency medical technician, paramedic, college professor, chiropractic physician, medical physician, physician executive, and clinical researcher. Holding an MBA in Healthcare Management and certified in Ketamine Assisted Psychotherapy, he has made significant contributions to the fields of emergency medical services, clinical nutrition, chiropractic care, general medicine, functional and regenerative medicine, and healthcare management. Dr. Rosado is also a distinguished national and international speaker, author, and consultant, recognized for his commitment to advancing patient care, pioneering medical innovations, and advocating for medical cannabis.
Robert Yrshus, the Executive Chairman of VitalPoint Technologies Inc., expressed his enthusiasm for the new appointment: “We are delighted to welcome Dr. Joseph Rosado to our team. His unparalleled expertise and passion for advancing medical treatments are perfectly aligned with our mission to provide innovative healthcare solutions. We are confident that under his guidance, our ketamine therapy clinics will set new standards in patient care and treatment efficacy.”
Dr. Rosado also shared his excitement about joining VitalPoint Technologies Inc.: “I am honored to join VitalPoint at such a pivotal time in its journey. Ketamine therapy holds immense potential in treating various chronic mental and behavioral health conditions, and I am eager to contribute to the development of these clinics. Together, we can make a significant impact on patient lives and the broader healthcare landscape.”
VitalPoint Technologies Inc. is committed to leveraging Dr. Rosado’s expertise to establish state-of-the-art ketamine therapy clinics that offer transformative care for patients. This strategic move underscores the company’s dedication to enhancing patient outcomes through innovative medical solutions.
About Dr. Joseph Rosado
Dr. Joseph Rosado is a distinguished healthcare professional with over 40 years of extensive experience in various medical fields, including emergency medical services, clinical nutrition, chiropractic care, general medicine, and healthcare management. His career is particularly notable for his pioneering work in alternative medicine, with a focus on medical cannabis and ketamine-assisted therapies.
Dr. Rosado’s journey in alternative medicine began with his foundational education, which includes a Bachelor of Science in Clinical Nutrition and a Doctor of Chiropractic degree from Life University, a medical degree from Universidad Central del Este, and an MBA in Health Care Management from the University of Phoenix. His academic background provided him with a comprehensive understanding of both conventional and alternative medical practices, setting the stage for his innovative approach to patient care.
As a forward-thinking advocate for medical cannabis, Dr. Rosado has made substantial contributions to the field through his research, clinical practice, and public speaking. His work in medical cannabis emphasizes its therapeutic potential for managing chronic conditions and improving quality of life. Dr. Rosado has become a leading voice on this topic, frequently engaging as a national and international speaker and consultant. His expertise in this area is highlighted by his bestselling book, Hope and Healing: A Case for Medical Cannabis, which offers a compelling argument for the integration of medical cannabis into mainstream healthcare.
In addition to his work with medical cannabis, Dr. Rosado has also been at the forefront of ketamine-assisted psychotherapy. Certified in Ketamine Assisted Psychotherapy, he has explored its use in treating conditions such as depression, anxiety, and PTSD. Dr. Rosado’s involvement in this emerging field reflects his commitment to advancing innovative treatments that address complex mental health issues. His approach combines traditional medical practices with cutting-edge therapies, aiming to provide holistic and effective care for his patients.
Throughout his career, Dr. Rosado has held key leadership roles, including Medical Director at Tricounty Hospital, Med Diagnostic Inc., Family Health Source, Complete Wellness Medical Centers, and Panacea Alliance. He currently serves as an Adjunct Professor at Lake Erie College of Osteopathic Medicine and is the Owner/CEO of International Medical Consultants, Inc. His role as a consultant and speaker on medical cannabis and ketamine-assisted therapies has earned him recognition and respect within the global medical community. Dr. Rosado actively participates on scientific advisory boards for international organizations, further advancing his mission to integrate alternative therapies into standard medical practices.
Dr. Rosado’s contributions to alternative medicine, particularly in the realms of medical cannabis and ketamine-assisted psychotherapy, reflect his unwavering dedication to enhancing patient care and pioneering innovative treatments. His career is a testament to his commitment to exploring and implementing alternative therapies that offer new hope and healing for patients facing chronic and mental health conditions.
Website: https://josephrosadomd.com/
About VitalPoint Technologies, Inc.:
VitalPoint Technologies, Inc. is a tech-enabled healthcare platform dedicated to researching, developing, educating and improving accessibility for alternative healthcare options. Founded by veterans, medical professionals, and financial advocates, VitalPoint Technologies, Inc. is committed to innovative solutions like CBD, ketamine, MDMA and psilocybin, the company addresses critical issues such as veteran suicides, opioid addiction, and treatment-resistant mental health conditions. Headquartered in Houston, Texas, it benefits from proximity to the Texas Medical Center, the largest medical city in the world, and the second-largest veteran population in the United States, with over 300,000 veterans.
Corporate Website: https://VitalPointTech.com
Herban Healing: https://Herban-Healing.com
Contact:
Robert Yrshus, Executive Chairman
Address: 3730 Kirby Drive # 1200
Houston, TX 77098
Phone: 1-512-522-0360
Email: [email protected]
Forward-Looking Statements Certain statements herein, including statements regarding the extent and timing of our production and other operations, and our liquidity, are “forward-looking statements” that are subject to risks and uncertainties. These forward-looking statements are based on management’s current expectations. Various important factors could cause actual results to differ materially, including the risks identified in our filings with the Securities and Exchange Commission. VitalPoint Technologies, Inc. disclaim any obligation to update this information. Certain statements in this press release are forward-looking and involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.
None of the statements in this announcement or via any web sites linked herein have been evaluated by the FDA. Furthermore, none of the statements in this announcement or any web sites linked herein should be construed as dispensing medical advice or making claims regarding the cure of diseases. You should consult a licensed health care professional before starting any supplement, dietary, or exercise program, especially if you are pregnant or have any pre-existing injuries or medical conditions. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any diseases.
Read Full Disclaimer: https://vitalpointtech.com/disclaimer/